Albion Financial Group’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6
Closed -$38 495
2023
Q1
$38 Hold
6
﹤0.01% 441
2022
Q4
$40 Hold
6
﹤0.01% 479
2022
Q3
$0 Hold
6
﹤0.01% 564
2022
Q2
$0 Hold
6
﹤0.01% 621
2022
Q1
$0 Hold
6
﹤0.01% 668
2021
Q4
$0 Hold
6
﹤0.01% 689
2021
Q3
$0 Hold
6
﹤0.01% 544
2021
Q2
$0 Buy
+6
New +$111 ﹤0.01% 530
2020
Q4
$0 Buy
+13
New +$173 ﹤0.01% 503

Other funds holding TOKE

Albion Financial Group's TOKE Position: Q2 2023 in Review

Albion Financial Group sold out of Cambria Cannabis ETF (TOKE) in Q2 2023, closing a stake of 6 shares — an estimated $38 sold.

Albion Financial Group first reported a position in TOKE in Q4 2020 and held it in 9 quarters. The position peaked at $40 in Q4 2022. 21 funds tracked by Wall St. Rank hold TOKE as of Q2 2023.

  • Albion Financial Group reported no remaining Cambria Cannabis ETF position as of Q2 2023 after selling out during the quarter.
  • Albion Financial Group sold 6 Cambria Cannabis ETF shares in Q2 2023, an estimated $38.
  • Albion Financial Group first reported a position in Cambria Cannabis ETF in Q4 2020 and held it in 9 quarters.
  • Albion Financial Group's Cambria Cannabis ETF position peaked at $40 in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q2 2023.

Based on Albion Financial Group's 13F filing for Q2 2023, filed 25 Jul 2023.